General Information
Drug ID
DR00399
Drug Name
Valproic Acid
Synonyms
2 PP (base); 2-Propylpentanoic acid; 2-Propylvaleric acid; 2-n-Propyl-n-valeric acid; 4-Heptanecarboxylic acid; Abbott 44090; Acide valproique; Acide valproique [INN-French]; Acido valproico; Acido valproico [INN-Spanish]; Acidum valproicum; Acidum valproicum [INN-Latin]; Alti-Valproic; Avugane; Baceca; Convulex; Convulex (TN); Convulsofin; Depacon (TN); Depakene; Depakene (TN); Depakin; Depakin chrono; Depakine; Depakine chrono; Depakote (TM); Depakote (TN); Depakote ER (TN); Deproic; Di-n-propylacetic acid; Di-n-propylessigsaeure; Di-n-propylessigsaure; Di-n-propylessigsaure [German]; Dipropyl Acetate; Dipropylacetate; Dipropylacetic acid; Dom-Valproic; Encorate (TN); Epilim (TN); Epival (TN); Ergenyl; G2M-777; Kyselina 2-propylvalerova; Kyselina 2-propylvalerova [Czech]; Med Valproic; Mylproin; Myproic Acid; N-DPA; N-Dipropylacetic acid; Novo-Valproic; Nu-Valproic; PMS-Valproic Acid; Penta-Valproic; Propylvaleric acid; Savicol; Semisodium Valproate; Stavzor; Stavzor (TN); VPA; Valproate; Valproic Acid, Sodium Salt (2:1); Valproic acid (USP); Valproic acid USP; Valproic acid USP24; Valproic acid [USAN:INN:BAN]; Valproinsaeure; Vupral; Winthrop (TN)
Drug Type
Small molecular drug
Indication Epilepsy [ICD11: 8A6Z] Approved [1]
Therapeutic Class
Anticonvulsants
Structure
3D MOL 2D MOL
Formula
C8H16O2
Canonical SMILES
CCCC(CCC)C(=O)O
InChI
InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
InChIKey
NIJJYAXOARWZEE-UHFFFAOYSA-N
CAS Number
CAS 99-66-1
Pharmaceutical Properties Molecular Weight 144.21 Topological Polar Surface Area 37.3
Heavy Atom Count 10 Rotatable Bond Count 5
Hydrogen Bond Donor Count 1 Hydrogen Bond Acceptor Count 2
XLogP
2.8
PubChem CID
3121
PubChem SID
10539166 , 11335448 , 11360687 , 11363415 , 11364691 , 11365977 , 11367253 , 11368539 , 11369815 , 11372725 , 11372856 , 11374010 , 11375415 , 11376701 , 11377978 , 11461659 , 11484648 , 11488762 , 11491548 , 11492191 , 11494335 , 12015354 , 14710660 , 15321539 , 17389523 , 24898751 , 26697333 , 26752920 , 26752921 , 29222263 , 3138784 , 399407 , 46260925 , 46505925 , 48416692 , 48424277 , 48425730 , 4918409 , 49635685 , 49640649 , 49856166 , 50062089 , 50105536 , 53788878 , 56310655 , 621684 , 7847465 , 7980632 , 8151988 , 9394
ChEBI ID
ChEBI:39867
TTD Drug ID
D0Y3KG
DT(s) Transporting This Drug MCT2 Transporter Info Monocarboxylate transporter 2 Substrate [2]
MRP2 Transporter Info Multidrug resistance-associated protein 2 Substrate [3]
References
1 Valproic Acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Monocarboxylate Transporters in Drug Disposition: Role in the Toxicokinetics and Toxicodynamics of the Drug of Abuse GHB.
3 Pharmacogenetics of membrane transporters: an update on current approaches. Mol Biotechnol. 2010 Feb;44(2):152-67.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.